Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology

Cancer immunotherapy utilizes the immune system to fight cancer and has already moved from the laboratory to clinical application. However, and despite excellent therapeutic outcomes in some hematological and solid cancers, the regular clinical use of cancer immunotherapies reveals major limitations...

詳細記述

書誌詳細

出版年:	Cells
主要な著者:	Ernesto Bockamp, Sebastian Rosigkeit, Dominik Siegl, Detlef Schuppan
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2020-09-01
主題:	immune checkpoint inhibitor CAR T cell therapy bi-specific antibody therapy tumor microenvironment macrophage myeloid derived suppressor cells (MDSC)
オンライン･アクセス:	https://www.mdpi.com/2073-4409/9/9/2102